Geneos Wealth Management Inc. Atara Biotherapeutics, Inc. Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$4.69 - $9.84 $10,177 - $21,352	-2,170 Closed	0 $0
Q1 2021 Jun 17, 2021	BUY	$14.0 - $20.72 $30,380 - $44,962	2,170 New	2,170 $30,000
Q4 2020 May 19, 2021	SELL	$12.67 - $26.23 $4,877 - $10,098	-385 Closed	0 $0
Q3 2019 Sep 07, 2021	BUY	$12.03 - $19.94 $4,631 - $7,676	385 New	385 $5,000
Q1 2018 Sep 07, 2021	SELL	$18.0 - $48.35 $2,700 - $7,252	-150 Closed	0 $0

Q3 2017 Sep 07, 2021	BUY	$13.25 - $17.05 $1,987 - $2,557	150	150 $2,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.